Consumers will be able to buy rapid coronavirus tests without a prescription this week at three national chain retailers, an expansion that comes as the nation's vaccination effort accelerates and states relax distancing requirements and mask mandates. 

The U.S. put the use of this particular vaccine on hold because of new questions about a potential rare, but serious, side effect: blood clots in the brain.

Friday April 16, 2021 12:00-12:30 ET Join experts from the Johns Hopkins Coronavirus Resource Center (CRC) at 12pm ET on Fridays for timely, accessible updates on the state of the pandemic and the public health response.

Getting COVID-19 between doses doesn’t mean that you need to restart the series or forego the second dose altogether.

If you're one of the 7 million Americans who received the Johnson & Johnson (J&J) COVID-19 vaccine, you may be wondering how the government's new recommendation to pause its use impacts you.

On Tuesday, the CDC and FDA recommended that administration of Johnson & Johnson’s COVID-19 vaccine be paused while a possible connection to rare blood clots is investigated. 

The U.S. has continued a downward trend, with a 30% decrease in the number of daily COVID-19 tests.

The United States has suffered nearly one-fifth of the world’s COVID-19 deaths, even as it accounts for just over 4 percent of the world’s population.

Campaigns aimed at Black communities across the U.S. are making headway in the effort to persuade people that the COVID-19 vaccines are safe and effective. 

Last week, the Centers for Disease Control and Prevention announced that fully vaccinated people can now travel safely on mass transportation, including planes, in the United States.

Friday April 9, 2021 12:00-12:30 ET Join experts from the Johns Hopkins Coronavirus Resource Center (CRC) at 12pm ET on Fridays for timely, accessible updates on the state of the pandemic and the public health response.

Johns Hopkins Center for Health Security Senior Scholar Jennifer Nuzzo discusses COVID risks associated with crowd interactions and contact, concerns about the AstraZeneca Plc vaccine, and states removing mask mandates.